{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:50:37Z","timestamp":1777265437280,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,26]]},"DOI":"10.7759\/cureus.107767","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:30:31Z","timestamp":1777264231000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical Expression of Vimentin in Breast Carcinoma and Its Correlation With Histopathological Prognostic Factors"],"prefix":"10.7759","author":[{"given":"Rashmi","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya","family":".","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston CW","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19:403-10. 10.1111\/j.1365-2559.1991.tb00229.x","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter CL","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63:181-7. 10.1002\/1097-0142(19890101)63:1&lt;181::aid-cncr2820630129&gt;3.0.co;2-h","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri R","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009, 119:1420-8. 10.1172\/JCI39104","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-151639","article-title":"Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition","volume":"24","author":"Mendez MG","year":"2010","unstructured":"Mendez MG, Kojima S, Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010, 24:1838-51. 10.1096\/fj.09-151639","journal-title":"FASEB J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2007.03.040","article-title":"Novel functions of vimentin in cell adhesion, migration, and signaling","volume":"313","author":"Ivaska J","year":"2007","unstructured":"Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007, 313:2050-62. 10.1016\/j.yexcr.2007.03.040","journal-title":"Exp Cell Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli A","year":"2011","unstructured":"Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011, 68:3033-46. 10.1007\/s00018-011-0735-1","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.756","article-title":"High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion","volume":"4","author":"Lehtinen L","year":"2013","unstructured":"Lehtinen L, Ketola K, M\u00e4kel\u00e4 R, Mpindi JP, Viitala M, Kallioniemi O, Iljin K. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion. Oncotarget. 2013, 4:48-63. 10.18632\/oncotarget.756","journal-title":"Oncotarget"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711570406","article-title":"Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium","volume":"157","author":"Raymond WA","year":"1989","unstructured":"Raymond WA, Leong AS. Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J Pathol. 1989, 157:299-306. 10.1002\/path.1711570406","journal-title":"J Pathol"},{"key":"ref11","article-title":"Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction","volume":"136","author":"Domagala W","year":"1990","unstructured":"Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol. 1990, 136:219-27.","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.5.441","article-title":"Vimentin expression in benign and malignant breast epithelium","volume":"46","author":"Heatley M","year":"1993","unstructured":"Heatley M, Whiteside C, Maxwell P, Toner P. Vimentin expression in benign and malignant breast epithelium. J Clin Pathol. 1993, 46:441-5. 10.1136\/jcp.46.5.441","journal-title":"J Clin Pathol"},{"key":"ref13","article-title":"Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients","volume":"5","author":"Thomas PA","year":"1999","unstructured":"Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA, Hendrix MJ. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res. 1999, 5:2698-703.","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.90","article-title":"Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters","volume":"21","author":"Chen MH","year":"2008","unstructured":"Chen MH, Yip GW, Tse GM, et al.. Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol. 2008, 21:1183-91. 10.1038\/modpathol.2008.90","journal-title":"Mod Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2016.56938","article-title":"Immunohistochemical characteristics of basal-like breast cancer","volume":"20","author":"Badowska-Kozakiewicz AM","year":"2016","unstructured":"Badowska-Kozakiewicz AM, Budzik MP. Immunohistochemical characteristics of basal-like breast cancer. Contemp Oncol (Pozn). 2016, 20:436-43. 10.5114\/wo.2016.56938","journal-title":"Contemp Oncol (Pozn)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijpo.2021.099","article-title":"Ki67 and P53 expression in breast cancer and their correlation with clinicopathological parameters","volume":"8","author":"Gogoi S","year":"2021","unstructured":"Gogoi S, Das B, Borgohain M, et al.. Ki67 and P53 expression in breast cancer and their correlation with clinicopathological parameters. Indian J Pathol Oncol. 2021, 8:478-84. 10.18231\/j.ijpo.2021.099","journal-title":"Indian J Pathol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.118724","article-title":"Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters","volume":"50","author":"Hemalatha A","year":"2013","unstructured":"Hemalatha A, Suresh TN, Kumar ML. Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters. Indian J Cancer. 2013, 50:189-94. 10.4103\/0019-509X.118724","journal-title":"Indian J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1957.43","article-title":"Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years","volume":"11","author":"Bloom HJ","year":"1957","unstructured":"Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957, 11:359-77. 10.1038\/bjc.1957.43","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge SB","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010, 17:1471-4. 10.1245\/s10434-010-0985-4","journal-title":"Ann Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194985","article-title":"Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis","volume":"13","author":"Usman S","year":"2021","unstructured":"Usman S, Waseem NH, Nguyen TK, Mohsin S, Jamal A, Teh MT, Waseem A. Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis. Cancers (Basel). 2021, 13:10.3390\/cancers13194985","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.81","article-title":"Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas","volume":"57","author":"Cattoretti G","year":"1988","unstructured":"Cattoretti G, Andreola S, Clemente C, D'Amato L, Rilke F. Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer. 1988, 57:353-7. 10.1038\/bjc.1988.81","journal-title":"Br J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3862","article-title":"Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation","volume":"6","author":"Liu CY","year":"2015","unstructured":"Liu CY, Lin HH, Tang MJ, Wang YK. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget. 2015, 6:15966-83. 10.18632\/oncotarget.3862","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/482512-immunohistochemical-expression-of-vimentin-in-breast-carcinoma-and-its-correlation-with-histopathological-prognostic-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:30:35Z","timestamp":1777264235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/482512-immunohistochemical-expression-of-vimentin-in-breast-carcinoma-and-its-correlation-with-histopathological-prognostic-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.107767","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,26]]}}}